- Home
- LOCO vs ABEO Comparison
LOCO vs ABEO Comparison
Compare LOCO & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCO
- ABEO
- Stock Information
- Founded
- LOCO 1980
- ABEO 1974
- Country
- LOCO United States
- ABEO United States
- Employees
- LOCO N/A
- ABEO N/A
- Industry
- LOCO Restaurants
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- LOCO Consumer Discretionary
- ABEO Health Care
- Exchange
- LOCO Nasdaq
- ABEO Nasdaq
- Market Cap
- LOCO 323.7M
- ABEO 332.0M
- IPO Year
- LOCO 2014
- ABEO 1980
- Fundamental
- Price
- LOCO $10.63
- ABEO $6.83
- Analyst Decision
- LOCO Buy
- ABEO Strong Buy
- Analyst Count
- LOCO 2
- ABEO 6
- Target Price
- LOCO $18.00
- ABEO $18.17
- AVG Volume (30 Days)
- LOCO 175.1K
- ABEO 702.3K
- Earning Date
- LOCO 10-30-2025
- ABEO 08-14-2025
- Dividend Yield
- LOCO N/A
- ABEO N/A
- EPS Growth
- LOCO N/A
- ABEO N/A
- EPS
- LOCO 0.85
- ABEO 0.99
- Revenue
- LOCO $479,690,000.00
- ABEO $400,000.00
- Revenue This Year
- LOCO $6.29
- ABEO N/A
- Revenue Next Year
- LOCO $1.56
- ABEO $339.63
- P/E Ratio
- LOCO $12.53
- ABEO $6.91
- Revenue Growth
- LOCO 1.85
- ABEO N/A
- 52 Week Low
- LOCO $8.29
- ABEO $3.93
- 52 Week High
- LOCO $14.10
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- LOCO 52.39
- ABEO 52.71
- Support Level
- LOCO $10.40
- ABEO $6.70
- Resistance Level
- LOCO $10.74
- ABEO $7.15
- Average True Range (ATR)
- LOCO 0.26
- ABEO 0.31
- MACD
- LOCO 0.04
- ABEO -0.02
- Stochastic Oscillator
- LOCO 75.57
- ABEO 46.62
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.